Kebuzone
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 70–100 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.364 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).[1][2]
References[]
- ^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- ^ "NCATS Inxight: Drugs — KEBUZONE". drugs.ncats.io. Retrieved 2019-02-27.
Categories:
- Ketones
- Pyrazolidindiones
- Musculoskeletal system drug stubs